956486-48-9

Upstream product

• 105-83-9 3,3'-Diamino-N-methyldipropylamine 

Downstream Products

• 956486-87-6 Br^(1-)*C₄₉H₄₄F₆N₉O₅⁽¹⁺⁾ 
• 1150268-31-7 Br^(1-)*C₅₀H₄₄F₆N₉O₆⁽¹⁺⁾ 
• 1151655-04-7 Br^(1-)*C₅₉H₅₄F₆N₉O₆⁽¹⁺⁾ 
• 1151654-71-5 C₅₀H₄₄F₆N₁₀O₇S 
• 1151654-90-8 C₅₀H₄₅F₆N₉O₇S 
• 1151654-79-3 C₄₇H₃₉F₆N₉O₅ 
• 1151654-77-1 C₄₉H₄₂F₆N₁₀O₆ 
• 956487-06-2 C₄₈H₄₁F₆N₉O₆ 

Relevant academic research and scientific papers

4- (4-CYANOPHENYL) -1- (3-TRIFLUOROMETHYLPHENYL) -3,4, 6, 7-TETRAHYDRO-1H-PYRROLO [3, 4- D] PYRIMIDINE-2, 5-DIONE DERIVATIVES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS

Thirty six specific compounds having human neutrophil elastase inhibitory activity are disclosed, one of which has the structural formula (1). The compounds are useful inter alia for the treatment of inflammatory respiratory disease, and may be administer

3,4,6,7-TETRAHYDRO-1H-PYRROLO[3,4-D]PYRIMIDINE-2,5-DIONES AND THEIR THERAPEUTIC USE

Compounds in which two substituted 3,4,6,7-tetrahydro-1 H-pyrrolo[3,4-d]pyrimidine-2,5- dione molecules are covalently linked via a linker radical which has contains a betaine or zwitterionic motif are inhibitors of human neutrophil elastase activity, for

TETRAHYDROPYRROLOPYRIMIDINEDIONES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS

Compounds of formula (I) and multimers thereof are inhibitors of human neutrophil elastase activity, and of utility in the treatment of, e.g., COPD : wherein all the substituents are as defined in claim 1.

TETRAHYDROPYRROLOPYRIMIDINEDIONES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS

Compounds of formula (I) and multimers thereof are inhibitors of human neutrophil elastase activity, and utility in the treatment of, e.g., COPD: wherein all the substituents are as defined in claim 1.